Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Apr 15, 2021 12:46pm
96 Views
Post# 33003608

RE:RE:HC Wainwright March 8 webcast

RE:RE:HC Wainwright March 8 webcastHard to figure out what their IR strategy is, or if it will be ramped up based on milestones in their R&D, German plant PGX progress, any deals, etc.

Peter Lynch has stressed investing in what you know or where one could have an advantage. One would think that CZO employees, UofA and McMaster University researchers working with CZO would be buying shares and spreading the CZO story to friends and colleagues. 

At a minimum lets see if insiders buy when the lockout period is over just after release of Q4.


Stocker46 wrote: Ceapro's last 4 news releases have involved presentations at virtual conferences or meetings .. but unfortunately, they've done little to support the share price. In fact, the SP dropped to a low of 60 cents about 2 weeks ago ... the lowest it has been in over 5 months.
Hopefully the presentations at the EMFS meetings in early May will create some interest.

Disappointed their annual & 4th Q financials were not released today .. looks like April 22 now. You would think that with all the "exciting" developments, they might want to have a Conference Call to get the word out to investors .. but apparently not.  




<< Previous
Bullboard Posts
Next >>